Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens

Journal of Virology

Volumn 82, Issue 8, 2008, Pages 4125-4134

  Pastori, Claudia ^a   Clivio, Alberto ^b   Diomede, Lorenzo ^a   Consonni, Roberto ^c   De Mori, Giacomo M S ^d   Longhi, Renato ^d   Colombo, Giorgio ^d   Lopalco, Lucia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CNR   (Italy)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ASPARTIC ACID; CHEMOKINE RECEPTOR CCR5; GLYCINE; MUTANT PROTEIN; PHENYLALANINE; BLOCKING ANTIBODY; PEPTIDE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CHEMOTAXIS; CHICKEN; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOGENICITY; LYMPHOCYTE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; RECEPTOR DOWN REGULATION; STEREOSPECIFICITY; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; GENETICS; IMMUNOLOGY; LEUKOCYTE MIGRATION INHIBITION TEST; MOLECULAR GENETICS; SERODIAGNOSIS; SYNTHESIS; VIRUS ATTACHMENT;

ANIMALIA; GALLUS GALLUS; HUMAN IMMUNODEFICIENCY VIRUS; MUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, BLOCKING; CELL MIGRATION INHIBITION; CHICKENS; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HIV; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDES; RECEPTORS, CCR5; VIRUS ATTACHMENT;

EID: 41949120129     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02232-07     Document Type: Article

References (51)

1. Baleja, J. D., T. Mau, and G. Wagner. 1994. Recognition of DNA by GAL4 in solution: use of a monomeric protein-DNA complex for study by NMR. Biochemistry 33:3071-3078.
2. Barassi, C., A. Lazzarin, and L. Lopalco. 2004. CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. Blood 104:2205-2206.
3. Barassi, C., E. Soprana, C. Pastori, R. Longhi, E. Buratti, F. Lillo, C. Marenzi, A. Lazzarin, A. G. Siccardi, and L. Lopalco. 2005. Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy. J. Virol. 79:6848-6858.
4. Berendsen, H. J. C., J. R. Grigera, and T. P. Straatsma. 1987. The missing term in effective pair potentials. J. Phys. Chem. 91:6269-6271.
5. Berendsen, H. J. C., J. P. M. Postma, W. F. van Gunsteren, A. Di Nola, and J. R. Haak. 1984. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81:3684.
6. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
7. Binley, J. M., C. S. Cayanan, C. Wiley, N. Schulke, W. C. Olson, and D. R. Burton. 2003. Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J. Virol. 77:5678-5684.
8. Blaak, H., A. B. van't Wout, M. Brouwer, M. Cornelissen, N. A. Kootstra, N. Albrecht-van Lent, R. P. Keet, J. Goudsmit, R. A. Coutinho, and H. Schuitemaker. 1998. Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples. J. Virol. 72:218-224.
9. Bomsel, M., C. Pastori, D. Tudor, C. Alberti, S. Garcia, D. Ferrari, A. Lazzarin, and L. Lopalco. 2007. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells. AIDS 21:13-22.
10. Chelli, M., and M. Alizon. 2001. Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor. J. Biol. Chem. 276:46975-46982.
11. Cherezov, V., D. M. Rosenbaum, M. A. Hanson, S. G. F. Rasmussen, F. S. Thian, T. S. Kobilka, H. Choi, P. Kuhn, W. I. Weis, B. K. Kobilka, and R. C. Stevens. 2007. High resolution crystal structure of an engineered human β2 adrenergic G protein-coupled receptor. Science 318:1258-1265.
12. Clerici, M., C. Barassi, C. Devito, C. Pastori, S. Piconi, D. Trabattoni, R. Longhi, J. Hinkula, K. Broliden, and L. Lopalco. 2002. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS 16:1731-1741.
13. Cohen, J. 1997. Exploiting the HIV-chemokine nexus. Science 275:1261-1264.
14. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
15. Consonni, R., L. Santomo, P. Fusi, P. Tortora, and L. Zetta. 1999. A single-point mutation in the extreme heat- and pressure-resistant sso7d protein from Sulfolobus solfataricus leads to a major rearrangement of the hydrophobic core. Biochemistry 38:12709-12717.
16. Daura, X., K. Gademann, B. Jaun, D. Seebach, W. F. van Gunsteren, and A. E. Mark. 1999. Peptide folding: when simulation meets experiment. Angew. Chemie Intl. 38:236-240.
17. DeLano, W. L. 2002. The PyMOL molecular graphics system. DeLano Scientific, San Carlos, CA.
18. Dragic, T., A. Trkola, S. W. Lin, K. A. Nagashima, F. Kajumo, L. Zhao, W. C. Olson, L. Wu, C. R. Mackay, G. P. Allaway, T. P. Sakmar, J. P. Moore, and P. J. Maddon. 1998. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J. Virol. 72:279-285.
19. 1H NMR spectra of proteins. Biochemistry 26:5953-5958.
20. Farzan, M., H. Choe, L. Vaca, K. Martin, Y. Sun, E. Desjardins, N. Ruffing, L. Wu, R. Wyatt, N. Gerard, C. Gerard, and J. Sodroski. 1998. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J. Virol. 72:1160-1164.
21. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35:161-214.
22. Frishman, D., and P. Argos. 1995. Knowledge-based protein secondary structure assignment. Proteins 23:566-579.
23. Hernanz-Falcón, P., J. M. Rodriguez-Frade, A. Serrano, D. Juan, A. del Sol, S. F. Soriano, F. Roncal, L. Gomez, A. Valencia, A. C. Martinez, and M. Mellado. 2004. Identification of amino acid residues crucial for chemokine receptor dimerization. Nat. Immunol. 5:216-223.
24. Huang, C. C., S. N. Lam, P. Acharya, M. Tang, S. H. Xiang, S. S. Hussan, R. L. Stanfield, J. Robinson, J. Sodroski, I. A. Wilson, R. Wyatt, C. A. Bewley, and P. D. Kwong. 2007. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317:1930-1934.
25. King, D. S., C. G. Fields, and G. B. Fields. 1990. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Protein Res. 36:255-266.
26. Klasse, P. J., and Q. J. Sattentau. 2002. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 83:2091-2108.
27. Klasse, P. J., R. Shattock, and J. P. Moore. 2008. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. Annu. Rev. Med. 59:291-307.
28. Konigs, C., A. Pustowka, J. Irving, C. Kessel, K. Klich, V. Wegner, M. J. Rowley, I. R. Mackay, W. Kreuz, C. Griesinger, and U. Dietrich. 2007. Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry. Immunol. Cell Biol. 85:511-517.
29. Lisziewicz, J., E. Rosenberg, J. Lieberman, H. Jessen, L. Lopalco, R. Siliciano, B. Walker, and F. Lori. 1999. Control of HIV despite the discontinuation of antiretroviral therapy. N. Engl. J. Med. 340:1683- 1684.
30. Lopalco, L. 2004. Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance? Curr. HIV Res. 2:127-139.
31. Lopalco, L., C. Barassi, C. Paolucci, D. Breda, D. Brunelli, M. Nguyen, J. Nouhin, T. T. Luong, L. X. Truong, M. Clerici, G. Calori, A. Lazzarin, G. Pancino, and S. E. Burastero. 2005. Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin. J. Gen. Virol. 86:339-348.
32. Lopalco, L., C. Barassi, C. Pastori, R. Longhi, S. E. Burastero, G. Tambussi, F. Mazzotta, A. Lazzarin, M. Clerici, and A. G. Siccardi. 2000. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro. J. Immunol. 164:3426-3433.
33. Marion, D., and K. Wuthrich. 1983. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113:967-974.
34. Mellado, M., J. M. Rodriguez-Frade, S. Manes, and A. C. Martinez. 2001. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol. 19:397-421.
35. Miyamoto, S., and P. A. Kollman. 1992. Settle: an analytical version of the shake and rattle algorithms for rigid water models. J. Comp. Chem. 13:952-962.
36. Moore, J. P. 1997. Coreceptors: implications for HIV pathogenesis and therapy. Science 276:51-52.
37. Parren, P. W., M. C. Gauduin, R. A. Koup, P. Poignard, P. Fisicaro, D. R. Burton, and Q. J. Sattentau. 1997. Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design. Immunol. Lett. 57:105-112.
38. Pastori, C., B. Weiser, C. Barassi, C. Uberti-Foppa, S. Ghezzi, R. Longhi, G. Calori, H. Burger, K. Kemal, G. Poli, A. Lazzarin, and L. Lopalco. 2006. Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression. Blood 107:4825-4833.
39. Paterlini, M. G. 2002. Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity. Biophys. J. 83:3012-3031.
40. Piotto, M., V. Saudek, and V. Sklenar. 1992. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2:661-665.
41. Rasmussen, S. G. F., H. Choi, D. M. Rosenbaum, T. S. Kobilka, F. S. Thian, P. C. Edwards, M. Burghammer, V. R. P. Ratnala, R. Sanishvili, R. F. Fischetti, G. F. X. Scheltler, W. I. Weis, and B. K. Kobilka. 2007. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450:383-388.
42. Rosenbaum, D. M., V. Cherezov, M. A. Hanson, S. G. Rasmussen, F. S. Thian, T. S. Kobilka, H. J. Choi, X. J. Yao, W. I. Weis, R. C. Stevens, and B. K. Kobilka. 2007. GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function. Science 318:1266- 1273.
43. Samson, M., G. LaRosa, F. Libert, P. Paindavoine, M. Detheux, G. Vassart, and M. Parmentier. 1997. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 272:24934- 24941.
44. Sedlak, J., and R. H. Lindsay. 1968. Estimation of total, protein bound, and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25:192-205.
45. van der Spoel, D., E. Lindahl, B. Hess, G. Groenhof, A. E. Mark, H. J. Berendsen. 2005. GROMACS: fast, flexible, and free. J. Comput. Chem. 26:1701-1718.
46. van Gunsteren, W. F., S. R. Billeter, A. A. Eising, P. H. Hunenberger, P. Kruger, A. E. Mark, W. R. P. Scott, and I. G. Tironi. 1996. Biomolecular simulation: the GROMOS96 manual and user guide. ETH, Zürich, Switzerland.
47. Vila-Coro, A. J., M. Mellado, A. Martin de Ana, P. Lucas, G. del Real, A. C. Martinez, and J. M. Rodriguez-Frade. 2000. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc. Natl. Acad. Sci. USA 97:3388-3393.
48. Wishart, D. S., B. D. Sykes, and F. M. Richards. 1992. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31:1647-1651.
49. Wütrich, K. 1986. NMR of proteins and nucleic acids. Wiley, New York, NY.
50. Zhang, Y., C. Pool, K. Sadler, H. P. Yan, J. Edl, X. Wang, J. G. Boyd, and J. P. Tam. 2004. Selection of active ScFv to G-protein-coupled receptor CCR5 using surface antigen-mimicking peptides. Biochemistry 43:12575-12584.
51. Zhu, L., M. C. van de Lavoir, J. Albanese, D. O. Beenhouwer, P. M. Cardarelli, S. Cuison, D. F. Deng, S. Deshpande, J. H. Diamond, L. Green, E. L. Halk, B. S. Heyer, R. M. Kay, A. Kerchner, P. A. Leighton, C. M. Mather, S. L. Morrison, Z. L. Nikolov, D. B. Passmore, A. Pradas-Monne, B. T. Preston, V. S. Rangan, M. Shi, M. Srinivasan, S. G. White, P. Winters-Digiacinto, S. Wong, W. Zhou, and R. J. Etches. 2005. Production of human monoclonal antibody in eggs of chimeric chickens. Nat. Biotechnol. 23:1159-1169.